Jami sof aktivlar: Nautilus Bio (NAUT)

Ommaviy kompaniya Nautilus Biotechnology Inc (NAUT) logotipi

Biznes tijoratdan oldingi bosqichda bo'lganligi sababli, uning narxlar strategiyasi proteomikaning mass-spektrometriyaga nisbatan kelgusidagi samaradorligiga bog'liq. Ko'rsatkich 0.13 ga teng bo'lgan Nautilus Biotechnology (NAUT) aksiyalarining narxi retrospektivasi AI protein tahlili patentlari va qat'iy HIPAA qoidalarining ta'sirini ko'rsatadi. Hozirgi vaqtda Nautilus Biotechnology (NAUT) o'z texnologiyalarini rivojlantirish uchun jalb qilingan investitsiyalardan foydalangan holda, diagnostika vositalarini yaratishga e'tibor qaratmoqda.

Nautilus Biotechnology, Inc. (NAUT) - Kompaniyaning balans qiymati 04.07.2022dan 28.10.2026gacha

Nautilus Biotechnology Inc (NAUT) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Nautilus Biotechnology|NAUT - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Nautilus Biotechnology, Inc.|NAUT - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Nautilus Biotechnology|NAUT - Kompaniyaning balans qiymati|Kapitallashuvning balans qiymatiga nisbati nautilus.bio|NAUT - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Nautilus Biotechnology|NAUT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Nautilus Biotechnology|NAUT - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Nautilus Biotechnology, Inc.
Kompaniyaning fundamental baholanishi:Nautilus Biotechnology
Nautilus Bio yetakchi tovari

Yuqori sifatli aktivlarni tanlash uchun investorga bozor narxini sof aktivlarning haqiqiy qiymatidan majburiyatlarni ayirgan holda solishtirish zarurdir. Nautilus Biotechnology (NAUT) kompaniyasining ushbu buxgalteriya kapitalizatsiyasi kompaniyaning ichki moddiy bazasini aks ettiradi, bu esa uning inqilobiy proteom tahlili platformasiga bo'lgan yuqori bozor kutuvlari va brendning ilmiy nufuzi fonida kapital uchun himoya anshori vazifasini o'taydi.

Nautilus Biotechnology raqobatchilari tahlili

Tempus AI Inc (TEM) - Balans kapitallashuvi|QGEN - Kompaniyaning sof aktivlari|ionispharma.com (IONS) - Jami sof aktivlar|Balans kapitallashuvi Repligen (RGEN)|Buxgalteriya kapitallashuvi RNA|Kompaniyaning balans qiymati CRISPR Therapeutics Corp CRSP|Buxgalteriya kapitallashuvi GeneDx Corp (WGS)|Balans kapitallashuvi RARE (Ultragenyx Pharmaceutical)|beamtx.com - Balans kapitallashuvi|Sarepta (SRPT) - Kompaniyaning balans qiymati|TWST - Buxgalteriya kapitallashuvi|TXG: Balans kapitallashuvi|Balans kapitallashuvi Intellia Corp|STOK (Stoke Therapeutics) - Kompaniyaning sof aktivlari|Balans kapitallashuvi biolifesolutions.com (BLFS)|Kompaniyaning sof aktivlari Wave Life Sciences Ltd.|Jami sof aktivlar Maze Therapeutics, Inc. (MAZE)|Balans kapitallashuvi SION|Prime Medicine Bio - Biznesning balans bahosi|TSHA - Kompaniyaning balans qiymati|uniqure.com (QURE) - Kompaniyaning balans qiymati|MGTX: Kompaniyaning sof aktivlari|RGNX (REGENXBIO Inc) - Balans kapitallashuvi|SLDB: Kompaniyaning balans qiymati|Biznesning balans bahosi Ocugen Pharma (OCGN)|Pacific Biosciences (PACB) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati benitec.com (BNTC)|Balans kapitallashuvi Design Therapeutics, Inc. DSGN|Kompaniyaning balans qiymati Rocket Pharma RCKT|Balans kapitallashuvi FDMT (4D Molecular Therapeutics Inc)|LXEO: Biznesning balans bahosi|Kompaniyaning balans qiymati KRRO|Kompaniyaning xususiy kapitali editasmedicine.com|Silence Therapeutics plc (SLN) - Kompaniyaning sof aktivlari|Jami sof aktivlar ProQR Therapeutics NV|Codexis, Inc. - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Sangamo BioSciences (SGMO)|Metagenomi, Inc. - Balans kapitallashuvi|Kompaniyaning sof aktivlari Precision BioSciences Inc. DTIL|Balans kapitallashuvi Generation Bio Corp (GBIO)|BOLD: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati exicuretx.com|IMNN (Imunon) - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati PHIO (Phio Pharmaceuticals Corp)|Kompaniyaning xususiy kapitali MBIO|Kompaniyaning balans qiymati TransCode Therapeutics (RNAZ)|Kompaniyaning balans qiymati BNGO (bionanogenomics.com)|APDN: Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali bluebird bio, Inc BLUE|Balans kapitallashuvi IPA|omegatherapeutics.com (OMGA) - Biznesning balans qiymati|Kompaniyaning sof aktivlari OMIC|RGLS (Regulus Therapeutics, Inc.) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Syros (SYRS)|Buxgalteriya kapitallashuvi Telesis Bio, Inc|Balans kapitallashuvi TCON|Balans kapitallashuvi unitybiotechnology.com UBX